These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 12027425
1. Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions. Russell KA, Wiegert E, Schroeder DR, Homburger HA, Specks U. Clin Immunol; 2002 May; 103(2):196-203. PubMed ID: 12027425 [Abstract] [Full Text] [Related]
2. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. Choi HK, Liu S, Merkel PA, Colditz GA, Niles JL. J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466 [Abstract] [Full Text] [Related]
3. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, Limburg PC, Niles J, Pan G, Specks U, Westman K, Wieslander J, De Groot K, Gross WL. Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921 [Abstract] [Full Text] [Related]
4. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis]. Hagemo JS, Aasarød K, Moen T. Tidsskr Nor Laegeforen; 2002 May 10; 122(12):1185-8. PubMed ID: 12089844 [Abstract] [Full Text] [Related]
5. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, Lüdemann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ. Kidney Int; 1998 Mar 10; 53(3):743-53. PubMed ID: 9507222 [Abstract] [Full Text] [Related]
6. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off? Holle JU, Hellmich B, Backes M, Gross WL, Csernok E. Ann Rheum Dis; 2005 Dec 10; 64(12):1773-9. PubMed ID: 15843447 [Abstract] [Full Text] [Related]
7. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis. Teixeira L, Mahr A, Jaureguy F, Noël LH, Nunes H, Lefort A, Barry S, Deny P, Guillevin L. Rheumatology (Oxford); 2005 Feb 10; 44(2):247-50. PubMed ID: 15546964 [Abstract] [Full Text] [Related]
8. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Tervaert JW. Arthritis Rheum; 2000 Sep 10; 43(9):2025-33. PubMed ID: 11014352 [Abstract] [Full Text] [Related]
9. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies. Vermeersch P, Vervaeke S, Blockmans D, van Hoovels L, Mariën G, Vanmaele H, Bossuyt X. Clin Chim Acta; 2008 Nov 10; 397(1-2):77-81. PubMed ID: 18708041 [Abstract] [Full Text] [Related]
11. Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA. O'Donnell JL, Hayman MW, Spellerberg MB, McLellan AD, Brooksbank K, Chapman PT, Stamp LK. Pathology; 2007 Apr 10; 39(2):258-63. PubMed ID: 17454758 [Abstract] [Full Text] [Related]
12. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis. Sinico RA, Radice A, Corace C, DI Toma L, Sabadini E. Ann N Y Acad Sci; 2005 Jun 10; 1050():185-92. PubMed ID: 16014533 [Abstract] [Full Text] [Related]
13. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis]. Arranz O, Ara J, Rodríguez R, Poveda R, Serra A, Solé-Amigó J, Fort J, Mirapeix E, Darnell A. Nefrologia; 2001 Jun 10; 21(4):349-54. PubMed ID: 11816510 [Abstract] [Full Text] [Related]
14. Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction. Vassilopoulos D, Niles JL, Villa-Forte A, Arroliga AC, Sullivan EJ, Merkel PA, Hoffman GS. Arthritis Rheum; 2003 Apr 15; 49(2):151-5. PubMed ID: 12687504 [Abstract] [Full Text] [Related]
15. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis. Liu LJ, Chen M, Yu F, Zhao MH, Wang HY. Nephrology (Carlton); 2008 Oct 15; 13(7):629-35. PubMed ID: 18775059 [Abstract] [Full Text] [Related]
16. [Antineutrophil cytoplasmic antibody(ANCA)]. Yoshida M. Rinsho Byori; 2003 Jul 15; 51(7):644-8. PubMed ID: 12924248 [Abstract] [Full Text] [Related]
17. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis. Russell KA, Fass DN, Specks U. Arthritis Rheum; 2001 Feb 15; 44(2):463-8. PubMed ID: 11229478 [Abstract] [Full Text] [Related]
18. [Clinical significance of anti-neutrophil cytoplasmic antibody and pathogenetic role of adhesion molecules for Wegener's granulomatosis]. Takizawa M. Hokkaido Igaku Zasshi; 1996 Jul 15; 71(4):517-29. PubMed ID: 8809575 [Abstract] [Full Text] [Related]
19. [Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment]. Zhang X, Jiang M, Chui J, Wang H, Ma J. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug 15; 19(4):284-7. PubMed ID: 10453568 [Abstract] [Full Text] [Related]